Background Cases of human monkeypox are rarely seen outside of west and central Africa.
There are few data regarding viral kinetics or the duration of viral shedding and no licensed …

Antibody responses to SARS-CoV-2 can be detected in most infected individuals 10–15 d
after the onset of COVID-19 symptoms. However, due to the recent emergence of SARS-CoV-…

Global dispersal and increasing frequency of the SARS-CoV-2 spike protein variant D614G
are suggestive of a selective advantage but may also be due to a random founder effect. We …

Objective To characterise the clinical features of monkeypox infection in humans. Design
Descriptive case series. Setting A regional high consequences infectious disease centre with …

We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike ΔH69/V70
in multiple independent lineages, often occurring after acquisition of receptor binding motif …

Background The SARS-CoV-2 variant B.1.1.7 was first identified in December, 2020, in
England. We aimed to investigate whether increases in the proportion of infections with this …

COVID-19 vaccine design and vaccination rollout need to take into account a detailed
understanding of antibody durability and cross-neutralizing potential against SARS-CoV-2 and …

Background Lateral flow devices (LFDs) for rapid antigen testing are set to become a cornerstone
of SARS-CoV-2 mass community testing, although their reduced sensitivity compared …

Background Clinical metagenomics (CMg) has the potential to be translated from a research
tool into routine service to improve antimicrobial treatment and infection control decisions. …

… b,c ; Simons, Rebecca a ; Douthwaite, Sam T. c ; Lee, Ming J. a … b Centre for Clinical
Infection & Diagnostics Research, King's College London … Pan F, Ye T, Sun P, Gui S …